Prologue, Flagship's newest startup, looks to mine viruses for new drugs [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
Prologue is starting out with $50 million and what it claims is the largest known database of viral protein structures. With the help of machine learning tools, the startup plans to mine that database for proteins that can point the way to new medicines. The startup hasn't said which specific diseases it will go after first or identified a lead program. CEO and Flagship origination partner Lovisa Afzelius said the company's approach could unearth drugs “across nearly any therapeutic area.” Prologue will use the initial funding to hire staff and build up research and development capabilities, the company said. Dive Insight: Flagship is known for betting on drugmaking platforms. The firm created messenger RNA specialist Moderna, brain drug developer Denali Therapeutics and many other companies touting new ways to find medicines. It currently has more than 40 startups in its portfolio. The firm has kept its focus even as investors have shifted attention to safer bets , and as so
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy? [Yahoo! Finance]Yahoo! Finance
- Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech [Yahoo! Finance]Yahoo! Finance
- Moderna vaccine patent upheld by European Patent Office: report [Seeking Alpha]Seeking Alpha
- Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at Evercore ISI to a "hold" rating.MarketBeat
MRNA
Earnings
- 5/2/24 - Beat
MRNA
Sec Filings
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- 5/15/24 - Form 144
- MRNA's page on the SEC website